Amanote Research
Register
Sign In
Clinical Anticancer Drug Development: Targeting the Cyclin-Dependent Kinases
British Journal of Cancer
- United Kingdom
doi 10.1038/sj.bjc.6602229
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
November 23, 2004
Authors
C Benson
S Kaye
P Workman
M Garrett
M Walton
J de Bono
Publisher
Springer Nature
Related search
Cyclin-Dependent Kinases as Drug Targets for Cell Growth and Proliferation Disorders. A Role for Systems Biology Approach in Drug Development. Part I—Cyclin-Dependent Kinases as Drug Targets in Cancer
Biotechnology and Biotechnological Equipment
Biotechnology
Cyclin-Dependent Kinases: A Family Portrait
Nature Cell Biology
Cell Biology
Development of Highly Potent and Selective Diaminothiazole Inhibitors of Cyclin-Dependent Kinases
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Inhibitors of Mammalian G1 Cyclin-Dependent Kinases.
Genes and Development
Genetics
Developmental Biology
Cyclin-Dependent Kinases and Cell Division in Plants: The Nexus
Plant Cell
Plant Science
Cell Biology
Cell-Specific Responses to Loss of Cyclin-Dependent Kinases
Oncogene
Cancer Research
Genetics
Molecular Biology
Targeting the Messengers: Serine/Threonine Protein Kinases as Potential Targets for Antimycobacterial Drug Development
IUBMB Life
Biochemistry
Genetics
Clinical Biochemistry
Cell Biology
Molecular Biology
Anticancer Drug Development: The Way Forward
Oncologist
Cancer Research
Medicine
Oncology
Are All Cyclin-Dependent Kinases 4/6 Inhibitors Created Equal?
npj Breast Cancer
Oncology
Radiology
Nuclear Medicine
Pharmacology
Imaging
